A Tumor Necrosis Factor-α and Hypoxia-Induced Secretome Therapy for Myocardial Repair
- 1 March 2018
- journal article
- conference paper
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 105 (3) , 715-723
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Post-myocardial Infarct Inflammation and the Potential Role of Cell TherapyCardiovascular Drugs and Therapy, 2015
- Mesenchymal stem cell therapy for heart diseaseVascular Pharmacology, 2012
- Marrow Stromal Cells for Cell-Based Therapy: The Role of Antiinflammatory Cytokines in Cellular CardiomyoplastyThe Annals of Thoracic Surgery, 2010
- Modification of mesenchymal stem cells for cardiac regenerationExpert Opinion on Biological Therapy, 2010
- Paracrine Mechanisms in Adult Stem Cell Signaling and TherapyCirculation Research, 2008
- Stem-cell therapy for cardiac diseaseNature, 2008
- A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarctionEuropean Heart Journal, 2006
- Cardioprotection afforded by NF-κB ablation is associated with activation of Akt in mice overexpressing TNF-αAmerican Journal of Physiology-Heart and Circulatory Physiology, 2006
- Identification of a Novel Role for Sphingolipid Signaling in TNF α and Ischemic Preconditioning Mediated CardioprotectionJournal of Molecular and Cellular Cardiology, 2002
- Tissue Expression and Immunolocalization of Tumor Necrosis Factor-α in Postinfarction Dysfunctional MyocardiumCirculation, 1999